)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Syngene International
Syngene International (SYNGENE) investor relations material
Syngene International Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary23 Jan, 2026
Executive summary
Q3 FY26 revenue from operations declined 3% year-on-year to INR 917 crore, mainly due to the impact from a single large molecule biologics product, while nine-month revenue grew 3% year-on-year to INR 2,702 crore.
Operating EBITDA margin for Q3 and nine months stood at 23%, with profit after tax before exceptional items at INR 73 crore for Q3 and INR 227 crore for nine months.
BMS extended its partnership through 2035, expanding integrated services and supporting over 700 scientists.
New commercial-scale facility for liquid-filled capsules commissioned and advanced chemistry labs added in Hyderabad.
Board approved unaudited financial results for Q3 and nine months ended December 31, 2025, with unqualified review reports.
Financial highlights
Q3 operating EBITDA was INR 209 crore (23% margin), down from 30% margin last year; PAT before exceptional items was down 44% year-on-year.
Q3 FY26 PAT before exceptional items: Rs 73 Cr, down 44% YoY; reported PAT for Q3 was INR 15 crore, down 89% YoY, impacted by an exceptional item of INR 58 crore due to new labor code-related gratuity liability.
Consolidated revenue from operations for Q3 FY26 was Rs. 9,171 million, up from Rs. 9,106 million in the previous quarter and Rs. 9,437 million in Q3 FY25.
Exceptional items in Q3 FY26 included a non-recurring expense of Rs. 706 million (consolidated) due to changes in labour laws.
Net cash balance as of December 31, 2025, was INR 902 crore.
Outlook and guidance
Full-year revenue expected to decline 3%-5% in constant currency, with operating EBITDA margin in the 22%-23% range.
CapEx for the year estimated at $45 million, with continued investment in new technologies, AI, and advanced processes.
The impact from the single large molecule product is expected to continue into the coming quarters, beyond Q4.
Management focus is on accelerating growth in other business areas and monitoring regulatory changes.
US biologics site acquisition: strategic impact?
Explain Labour Code impact on Q3 financials.
Bangalore facility: operational significance?
Quantify single product revenue impact in FY27
CDMO capacity utilization acceleration plan
New large client relationships and diversification
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Syngene International earnings date
Q4 25/2623 Apr, 2026
Syngene International
Next Syngene International earnings date
Q4 25/2623 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Syngene International Ltd engages in the provision of contract research and manufacturing services to the pharmaceutical, nutrition, and plant biology industries. It offers a comprehensive range of services from discovery support to manufacture of life-enabling therapies.
The company is involved in three principal activities: providing drug discovery research services; drug development services; and manufacture of active pharmaceutical ingredients & Intermediates, Recombinant proteins, Bioagrochemicals, Biosimilars & Biogenerics and also offering third party research & manufacturing services, including custom synthesis projects. The company was incorporated in 1993 and is headquartered in Bengaluru, India.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage